File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/cncr.24550
- Scopus: eid_2-s2.0-70350501255
- PMID: 19642173
- WOS: WOS:000271167900012
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation
Title | Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation | ||||||||
---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||
Keywords | Adenosine diphosphate-ribosylation factor 6 Epidermal growth factor Glioma Signaling pathway SP1 | ||||||||
Issue Date | 2009 | ||||||||
Publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/28741 | ||||||||
Citation | Cancer, 2009, v. 115 n. 21, p. 4959-4972 How to Cite? | ||||||||
Abstract | BACKGROUND: Epidermal growth factor (EGF) signaling plays a pivotal role in gliomagenesis. The authors previously demonstrated that adenosine diphospate-ribosylation factor 6 (ARF6), a member of the Ras-related small guanosine-50-triphospate-binding protein family, is required for EFA6A-induced glioma cell migration and invasion. However, the role of ARF6 in EGF signaling is unknown. METHODS: The authors analyzed messenger RNA (mRNA) levels of ARF6 and EGF receptor (EGFR) in 16 high-grade glioma samples and in 6 low-grade glioma samples by reverse transcriptase-polymerase chain reaction analysis. To determine whether EGF induces ARF6 expression in human glioblastoma U87 cells through transcriptional regulation and EGFR activation, the levels of ARF6 were assayed in EGF-treated U87 cells that were preincubated with a transcriptional inhibitor (actinomycin D) and an EGFR tyrosine kinase inhibitor (PD153035), respectively. The downstream signaling of EGFR-mediated ARF6 up-regulation also was investigated using specific inhibitors of mitogen-activated protein kinase (MEK), phosphatidylinositol 30 kinase (PI3K), and Janus kinase 2. The involvement of SP1 in the downstream signaling was studied by using an SP1 inhibitor (mithramycin A). Small-interfering RNAs (siRNAs) targeting ARF6 were used to investigate the effects of ARF6 on EGF-mediated glioma cell proliferation. RESULTS: The results demonstrated that ARF6 and EGFR mRNA levels were elevated in glioma tissues. Furthermore, EGF stimulated ARF6 expression in U87 cells in a dose-dependent and time-dependant manner. This stimulation was caused by increased transcription of ARF6 and by activation of the MEK/extracellular signal-regulated kinase 1 and 2 (ERK1/2) and PI3K signaling pathways. It is noteworthy that SP1 was essential for EGF-induced ARF6 up-regulation. Finally, EGF-induced glioblastoma cell proliferation depended on ARF6, because the suppression of ARF6 by siRNA or by a dominant-negative mutant significantly inhibited EGF-induced cell proliferation. CONCLUSIONS: The results of the current study suggested that EGF-induced ARF6 expression plays a significant role in glioma cell proliferation. © 2009 American Cancer Society. | ||||||||
Persistent Identifier | http://hdl.handle.net/10722/68948 | ||||||||
ISSN | 2023 Impact Factor: 6.1 2023 SCImago Journal Rankings: 2.887 | ||||||||
ISI Accession Number ID |
Funding Information: Supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (CUHK467507 to H.F.K. and HKU7705/07M to M.C.L.); donations for Li Ka Shing Institute of Health Sciences; and the Foundation of Guangzhou Science and Technology Bureau (2005J1-C0311 to H.F-K). | ||||||||
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, M | en_HK |
dc.contributor.author | Wang, J | en_HK |
dc.contributor.author | Ng, SSM | en_HK |
dc.contributor.author | Chan, CY | en_HK |
dc.contributor.author | He, ML | en_HK |
dc.contributor.author | Yu, F | en_HK |
dc.contributor.author | Lai, L | en_HK |
dc.contributor.author | Shi, C | en_HK |
dc.contributor.author | Chen, Y | en_HK |
dc.contributor.author | Yew, DT | en_HK |
dc.contributor.author | Kung, HF | en_HK |
dc.contributor.author | Lin, MCM | en_HK |
dc.date.accessioned | 2010-09-06T06:09:10Z | - |
dc.date.available | 2010-09-06T06:09:10Z | - |
dc.date.issued | 2009 | en_HK |
dc.identifier.citation | Cancer, 2009, v. 115 n. 21, p. 4959-4972 | en_HK |
dc.identifier.issn | 0008-543X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/68948 | - |
dc.description.abstract | BACKGROUND: Epidermal growth factor (EGF) signaling plays a pivotal role in gliomagenesis. The authors previously demonstrated that adenosine diphospate-ribosylation factor 6 (ARF6), a member of the Ras-related small guanosine-50-triphospate-binding protein family, is required for EFA6A-induced glioma cell migration and invasion. However, the role of ARF6 in EGF signaling is unknown. METHODS: The authors analyzed messenger RNA (mRNA) levels of ARF6 and EGF receptor (EGFR) in 16 high-grade glioma samples and in 6 low-grade glioma samples by reverse transcriptase-polymerase chain reaction analysis. To determine whether EGF induces ARF6 expression in human glioblastoma U87 cells through transcriptional regulation and EGFR activation, the levels of ARF6 were assayed in EGF-treated U87 cells that were preincubated with a transcriptional inhibitor (actinomycin D) and an EGFR tyrosine kinase inhibitor (PD153035), respectively. The downstream signaling of EGFR-mediated ARF6 up-regulation also was investigated using specific inhibitors of mitogen-activated protein kinase (MEK), phosphatidylinositol 30 kinase (PI3K), and Janus kinase 2. The involvement of SP1 in the downstream signaling was studied by using an SP1 inhibitor (mithramycin A). Small-interfering RNAs (siRNAs) targeting ARF6 were used to investigate the effects of ARF6 on EGF-mediated glioma cell proliferation. RESULTS: The results demonstrated that ARF6 and EGFR mRNA levels were elevated in glioma tissues. Furthermore, EGF stimulated ARF6 expression in U87 cells in a dose-dependent and time-dependant manner. This stimulation was caused by increased transcription of ARF6 and by activation of the MEK/extracellular signal-regulated kinase 1 and 2 (ERK1/2) and PI3K signaling pathways. It is noteworthy that SP1 was essential for EGF-induced ARF6 up-regulation. Finally, EGF-induced glioblastoma cell proliferation depended on ARF6, because the suppression of ARF6 by siRNA or by a dominant-negative mutant significantly inhibited EGF-induced cell proliferation. CONCLUSIONS: The results of the current study suggested that EGF-induced ARF6 expression plays a significant role in glioma cell proliferation. © 2009 American Cancer Society. | en_HK |
dc.language | eng | en_HK |
dc.publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/28741 | en_HK |
dc.relation.ispartof | Cancer | en_HK |
dc.rights | Cancer. Copyright © John Wiley & Sons, Inc. | en_HK |
dc.subject | Adenosine diphosphate-ribosylation factor 6 | en_HK |
dc.subject | Epidermal growth factor | en_HK |
dc.subject | Glioma | en_HK |
dc.subject | Signaling pathway | en_HK |
dc.subject | SP1 | en_HK |
dc.title | Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0008-543X&volume=115&issue=21&spage=4959&epage=4972&date=2009&atitle=Adenosine+Diphosphate-ribosylation+Factor+6+is+Required+for+Epidermal+Growth+Factor-induced+Glioblastoma+Cell+Proliferation | en_HK |
dc.identifier.email | Wang, J: jidewang@gmail.com | en_HK |
dc.identifier.email | Ng, SSM: ssmng@hku.hk | en_HK |
dc.identifier.email | Lin, MCM: mcllin@hkucc.hku.hk | en_HK |
dc.identifier.authority | Wang, J=rp00491 | en_HK |
dc.identifier.authority | Ng, SSM=rp00767 | en_HK |
dc.identifier.authority | Lin, MCM=rp00746 | en_HK |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1002/cncr.24550 | en_HK |
dc.identifier.pmid | 19642173 | - |
dc.identifier.scopus | eid_2-s2.0-70350501255 | en_HK |
dc.identifier.hkuros | 161068 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-70350501255&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 115 | en_HK |
dc.identifier.issue | 21 | en_HK |
dc.identifier.spage | 4959 | en_HK |
dc.identifier.epage | 4972 | en_HK |
dc.identifier.isi | WOS:000271167900012 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Li, M=36067425800 | en_HK |
dc.identifier.scopusauthorid | Wang, J=35309087500 | en_HK |
dc.identifier.scopusauthorid | Ng, SSM=7403358718 | en_HK |
dc.identifier.scopusauthorid | Chan, CY=22033276600 | en_HK |
dc.identifier.scopusauthorid | He, ML=35080389700 | en_HK |
dc.identifier.scopusauthorid | Yu, F=36986533000 | en_HK |
dc.identifier.scopusauthorid | Lai, L=12445800200 | en_HK |
dc.identifier.scopusauthorid | Shi, C=55175343900 | en_HK |
dc.identifier.scopusauthorid | Chen, Y=24075600300 | en_HK |
dc.identifier.scopusauthorid | Yew, DT=7007034694 | en_HK |
dc.identifier.scopusauthorid | Kung, HF=7402514190 | en_HK |
dc.identifier.scopusauthorid | Lin, MCM=7404816359 | en_HK |
dc.identifier.issnl | 0008-543X | - |